0R55.L
BIOSENIC SA BIOSENIC ORD SHS
£0.00
-9.09%
2026-05-26
About BIOSENIC SA BIOSENIC ORD SHS
BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.
Key Fundamentals
EPS (TTM)
£-0.77
Revenue Growth (YoY)
-100.0%
Profit Margin
0.0%
Price/Book
-0.06
Beta
-1.60
Market Cap
£22,485
Avg Volume (10D)
4K
Recent Breakout Signals
No recent breakout signals detected for 0R55.L.
Recent Price Range (60 Days)
60D High
£0.00
60D Low
£0.00
Avg Volume
133K
Latest Close
£0.00
Get breakout alerts for 0R55.L
Sign up for Breakout Scanner to receive daily notifications when 0R55.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
BIOSENIC SA BIOSENIC ORD SHS (0R55.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0R55.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.